The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT04217291 · COMPLETED
Trial details
- NCT number
- NCT04217291
- Sponsor
- Suzhou Yabao Pharmaceutical R&D Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-10
- Primary completion
- 2021-07-09
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.